OBLN Stock Price, News & Analysis

OBLN

Company Description

OBLN (OTC: OBLN) is a publicly traded company.

OBLN stock has gained 211.9% over the past year.

This page provides a comprehensive overview of OBLN stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+211.86%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

OBLN (OBLN) stock. Over the past 12 months, the stock has gained 211.9%.

Latest News

View All

June 8, 2021

-3.19%

ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger

acquisition

May 24, 2021

+14.04%

Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences

acquisition

May 21, 2021

+30.04%

Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences

acquisition

May 18, 2021

+22.03%

Obalon Therapeutics Stockholders Special Meeting Adjourned to May 25, 2021

May 12, 2021

+13.31%

Obalon Announces First Quarter 2021 Financial Results

earnings

May 12, 2021

+13.31%

Obalon Therapeutics, Inc. Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc

acquisition

OBLN has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, earnings. View all OBLN news →

SEC Filings

View All

No SEC filings available for OBLN.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months